1-1 of 1
P. Vermeulen
Close
Save search
Sort by
Journal Articles

Assessment of Two Doses of Infliximab in Patients with Low/Intermediate Risk IPSS Myelodysplastic Syndrome (MDS): An EORTC Leukemia Group (LG) Randomized Phase II Trial (06023).

Free
Liliana Baila, Stefan Suciu, Petra Muus, Sergio Amadori, Michel Delforge, Gert Ossenkoppele, Dominik L.D. Selleslag, Antoine Thyss, Hilde Demuynk, Alain Gadisseur, P. Vermeulen, Carla De Boer, Heinz Zwierzina, T.M. de Witte
Journal: Blood
Blood (2007) 110 (11): 1456.
https://doi.org/10.1182/blood.V110.11.1456.1456
Published: 2007